Guardant Health: Great Buy On Dips For Strong Diagnostics Verticals Despite Premium Valuation

Guardant Health, Inc. (NASDAQ: GH ) is a biopharma company working on liquid biopsy tests for several illnesses, but mostly with a focus on oncology applications. Basically, their approach relies on genomic and digital technology to analyze patients' DNA samples andMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a graduate ...